260 related articles for article (PubMed ID: 16126317)
1. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
Krejcova-Kunesova G; Bartosova L; Kuca K
Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova J; Vasina L
J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
[TBL] [Abstract][Full Text] [Related]
5. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes.
Sevelová L; Kuca K; Krejcová-Kunesová G
Toxicology; 2005 Feb; 207(1):1-6. PubMed ID: 15590116
[TBL] [Abstract][Full Text] [Related]
6. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
Kassa J; Kunesova G
Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
11. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
14. In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Chem Biol Interact; 2010 Sep; 187(1-3):207-14. PubMed ID: 20223229
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasová JZ; Tesarová S; Kuca K; Musílek K
Acta Medica (Hradec Kralove); 2008; 51(4):215-21. PubMed ID: 19453087
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
Kassa J; Karasova J
J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
[TBL] [Abstract][Full Text] [Related]
17. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
Kassa J; Jun D; Kuca K; Bajgar J
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
Kassa J; Krejèová G
Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
